Sepsis induced cardiotoxicity by promoting cardiomyocyte cuproptosis

Jingru Yan1, Zhangyi Li2, Yilan Li1

  • 1Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150001, China; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, 150001, China.

Insights

Sepsis-induced cardiotoxicity, a major cause of death, is linked to cuproptosis. Key genes like CD274 and VEGFA show altered expression, revealing new molecular mechanisms for this condition.

Area of Science:

  • Cardiovascular biology
  • Molecular mechanisms of disease
  • Sepsis research

Background:

  • Sepsis-induced cardiotoxicity is a primary driver of sepsis-related mortality.
  • The precise molecular underpinnings of sepsis-induced cardiotoxicity remain largely unknown.
  • Identifying these mechanisms is crucial for developing targeted therapies.

Purpose of the Study:

  • To elucidate the key molecular mechanisms driving sepsis-induced cardiotoxicity.
  • To investigate the role of cuproptosis and N6-Methyladenosine (m6A) methylation in this condition.

Main Methods:

  • Utilized Gene Expression Omnibus (GEO) datasets (GSE63920, GSE44363, GSE159309) for sepsis-induced cardiotoxicity data.
  • Performed functional enrichment analysis (GO, KEGG) to identify related signaling pathways.
  • Examined the interplay between cuproptosis-related genes (CRGs) and m6A methylation in a mouse model.

Main Results:

  • Significantly altered expression of CRGs including CD274, CP, VEGFA, COX11, CCL8, MAP2K1, and AOC3 was observed.
  • A significant correlation was found between differentially regulated CRGs and m6A methylation genes.
  • Enrichment analysis highlighted pathways involved in immune response and cellular processes.

Conclusions:

  • Cuproptosis is strongly associated with the development of sepsis-induced cardiotoxicity.
  • Specific genes (CD274, CP, VEGFA, COX11, CCL8, MAP2K1, AOC3) are key players in this process.
  • The interplay between CRGs and m6A methylation offers novel insights into sepsis-induced cardiotoxicity mechanisms.
Abstract